IBDEI0MY ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10314,0)
 ;;=J69.1^^39^437^7
 ;;^UTILITY(U,$J,358.3,10314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10314,1,3,0)
 ;;=3^Pneumonitis d/t Inhalation of Oils/Essences
 ;;^UTILITY(U,$J,358.3,10314,1,4,0)
 ;;=4^J69.1
 ;;^UTILITY(U,$J,358.3,10314,2)
 ;;=^95664
 ;;^UTILITY(U,$J,358.3,10315,0)
 ;;=J68.9^^39^437^9
 ;;^UTILITY(U,$J,358.3,10315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10315,1,3,0)
 ;;=3^Respiratory Condition,Unspec d/t Chem/Gases/Fumes/Vapors
 ;;^UTILITY(U,$J,358.3,10315,1,4,0)
 ;;=4^J68.9
 ;;^UTILITY(U,$J,358.3,10315,2)
 ;;=^5008287
 ;;^UTILITY(U,$J,358.3,10316,0)
 ;;=J84.114^^39^437^1
 ;;^UTILITY(U,$J,358.3,10316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10316,1,3,0)
 ;;=3^Acute Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,10316,1,4,0)
 ;;=4^J84.114
 ;;^UTILITY(U,$J,358.3,10316,2)
 ;;=^340536
 ;;^UTILITY(U,$J,358.3,10317,0)
 ;;=J84.89^^39^437^6
 ;;^UTILITY(U,$J,358.3,10317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10317,1,3,0)
 ;;=3^Interstitial Pulmonary Diseases,Oth Spec
 ;;^UTILITY(U,$J,358.3,10317,1,4,0)
 ;;=4^J84.89
 ;;^UTILITY(U,$J,358.3,10317,2)
 ;;=^5008303
 ;;^UTILITY(U,$J,358.3,10318,0)
 ;;=J82.81^^39^437^5
 ;;^UTILITY(U,$J,358.3,10318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10318,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Chronic
 ;;^UTILITY(U,$J,358.3,10318,1,4,0)
 ;;=4^J82.81
 ;;^UTILITY(U,$J,358.3,10318,2)
 ;;=^24374
 ;;^UTILITY(U,$J,358.3,10319,0)
 ;;=J82.82^^39^437^4
 ;;^UTILITY(U,$J,358.3,10319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10319,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Acute
 ;;^UTILITY(U,$J,358.3,10319,1,4,0)
 ;;=4^J82.82
 ;;^UTILITY(U,$J,358.3,10319,2)
 ;;=^5159205
 ;;^UTILITY(U,$J,358.3,10320,0)
 ;;=J82.83^^39^437^3
 ;;^UTILITY(U,$J,358.3,10320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10320,1,3,0)
 ;;=3^Eosinophilic Asthma
 ;;^UTILITY(U,$J,358.3,10320,1,4,0)
 ;;=4^J82.83
 ;;^UTILITY(U,$J,358.3,10320,2)
 ;;=^5159206
 ;;^UTILITY(U,$J,358.3,10321,0)
 ;;=J82.89^^39^437^8
 ;;^UTILITY(U,$J,358.3,10321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10321,1,3,0)
 ;;=3^Pulmonary Eosinophilia,Other,NEC
 ;;^UTILITY(U,$J,358.3,10321,1,4,0)
 ;;=4^J82.89
 ;;^UTILITY(U,$J,358.3,10321,2)
 ;;=^5159207
 ;;^UTILITY(U,$J,358.3,10322,0)
 ;;=99367^^40^438^1^^^^1
 ;;^UTILITY(U,$J,358.3,10322,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10322,1,2,0)
 ;;=2^TEAM CONF W/O PT BY PHYS
 ;;^UTILITY(U,$J,358.3,10322,1,3,0)
 ;;=3^99367
 ;;^UTILITY(U,$J,358.3,10323,0)
 ;;=99368^^40^438^2^^^^1
 ;;^UTILITY(U,$J,358.3,10323,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10323,1,2,0)
 ;;=2^TEAM CONF W/O PT BY NONPHYS QHP,30 MIN
 ;;^UTILITY(U,$J,358.3,10323,1,3,0)
 ;;=3^99368
 ;;^UTILITY(U,$J,358.3,10324,0)
 ;;=99507^^40^439^22^^^^1
 ;;^UTILITY(U,$J,358.3,10324,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10324,1,2,0)
 ;;=2^HOME VISIT CATH MAINTAIN
 ;;^UTILITY(U,$J,358.3,10324,1,3,0)
 ;;=3^99507
 ;;^UTILITY(U,$J,358.3,10325,0)
 ;;=99509^^40^439^21^^^^1
 ;;^UTILITY(U,$J,358.3,10325,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10325,1,2,0)
 ;;=2^HOME VISIT ADL TRAINING
 ;;^UTILITY(U,$J,358.3,10325,1,3,0)
 ;;=3^99509
 ;;^UTILITY(U,$J,358.3,10326,0)
 ;;=99510^^40^439^24^^^^1
 ;;^UTILITY(U,$J,358.3,10326,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10326,1,2,0)
 ;;=2^HOME VISIT SING/M/FAM COUNS
 ;;^UTILITY(U,$J,358.3,10326,1,3,0)
 ;;=3^99510
 ;;^UTILITY(U,$J,358.3,10327,0)
 ;;=99511^^40^439^23^^^^1
